A carregar...
Spironolactone and Resistant Hypertension in Heart Failure With Preserved Ejection Fraction
BACKGROUND: Recent evidence suggests that the mineralocorticoid receptor antagonist spironolactone should be the preferred fourth-line antihypertensive treatment in resistant hypertension (RHTN). Whether spironolactone improves blood pressure (BP) control in heart failure with preserved ejection fra...
Na minha lista:
| Publicado no: | Am J Hypertens |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5861580/ https://ncbi.nlm.nih.gov/pubmed/29228101 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ajh/hpx210 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|